Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 01, 2016 12:53 ET | Source: Selecta Biosciences Inc

Selecta Biosciences Announces Publication in Nature Nanotechnology Describing Novel Approach for Improving the Efficacy and Safety Profile of Biologic Drugs

Published results from preclinical studies show the potential of Selecta’s proprietary SVP-Rapamycin (SEL-110) immune therapy to improve the efficacy and safety of biologic therapeuticsThe data...
August 01, 2016 10:05 ET | Source: Vaccinex, Inc.

Vaccinex Receives FDA Fast Track Designation for VX15 Antibody for the Treatment of Huntington’s Disease

ROCHESTER, N.Y., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Vaccinex, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VX15 as a potential...
August 01, 2016 09:00 ET | Source: Altimmune, Inc.

Altimmune Receives BARDA Contract of Up to $120.2 Million to Fund Clinical Development of First-In-Class Anthrax Vaccine Candidate NasoShield

GAITHERSBURG, Md., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that the Company was awarded a contract valued at up to $120.2...
August 01, 2016 07:30 ET | Source: Pacific Biosciences, Inc.

HistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing

MENLO PARK, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that HistoGenetics, a pioneer and global leader in high-resolution HLA...
August 01, 2016 07:30 ET | Source: Pacira Pharmaceuticals, Inc

New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known

Vast Majority of Surgeons Feel Pressure to Prescribe More Opioids than Patients Need Professional Athlete Gabrielle Reece Joins Campaign to Promote Discussions Before Surgery about Non-Opioid...
August 01, 2016 07:30 ET | Source: Vericel Corporation

Vericel to Host Second-Quarter 2016 Earnings Webcast and Conference Call on August 8, 2016

CAMBRIDGE, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
August 01, 2016 07:00 ET | Source: Selecta Biosciences Inc

Selecta Biosciences Appoints Timothy C. Barabe to Board of Directors

WATERTOWN, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for...
August 01, 2016 07:00 ET | Source: pSivida Corp

pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis

WATERTOWN, Mass. and NEW YORK, Aug. 01, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for eye diseases,...
August 01, 2016 07:00 ET | Source: Apricus Biosciences

Apricus Biosciences Announces Corporate Update and Second Quarter 2016 Financial Results Conference Call

SAN DIEGO, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
August 01, 2016 07:00 ET | Source: Evogene Ltd.

Evogene to Participate at Piper Jaffray Global Agriculture Symposium

REHOVOT, Israel, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel...